BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 6977469)

  • 21. [Immune profile in patients with Hodgkin's disease in long-term remission after cytostatic chemotherapy].
    Nagel GA; Pietra CD; Hartmann D; Rosenthal M; Albrecht R; Obrist R; Obrecht P
    Schweiz Med Wochenschr; 1979 Jan; 109(2):45-51. PubMed ID: 311514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lymphocyte subpopulations in non-Hodgkin's lymphoma during cytostatic therapy].
    Schnabel I; Fricke HJ; Jansa U; Lehmann G
    Z Gesamte Inn Med; 1979 Dec; 34(23):704-8. PubMed ID: 317767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lymphocyte surface markers during treatment of non-Hodgkin's lymphomas].
    Trepińska E; Burchardt K
    Z Gesamte Inn Med; 1981 Sep; 36(18):681-2. PubMed ID: 6976047
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dynamics of the immunological indices in lymphogranulomatosis following splenectomy and radiation therapy].
    Ankudinov VA; Asliaev LA; Khvorostenko MI; Krugovov BA; Kosse VA
    Vopr Onkol; 1981; 27(4):26-31. PubMed ID: 7233871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of Hodgkin's disease at Villejuif from 1964 to 1974].
    Tubiana M; Mathé G
    Rev Prat; 1974 Oct; 24(45):3981-2, 3985-91. PubMed ID: 4445768
    [No Abstract]   [Full Text] [Related]  

  • 26. [Role of splenectomy in impairing lymphocyte elimination in patients with lymphogranulomatosis].
    Kuz'mina EG; Bogatyreva TI; Baĭsogolov GD; Iarilin AA
    Vopr Onkol; 1986; 32(8):65-8. PubMed ID: 3765511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Choice of therapeutic methods during the 3d stage of Hodgkin's disease].
    Mazurowa A; Płuzańska A; Dmochowska M; Krykowski E; Fajndt S; Studencki E; Zadrozna O
    Pol Tyg Lek; 1978 Jul; 33(27):1073-5. PubMed ID: 693381
    [No Abstract]   [Full Text] [Related]  

  • 28. Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.
    Karande AA; Gulwani B; Advani SH; Gangal SG
    Neoplasma; 1982; 29(2):149-59. PubMed ID: 6981068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hodgkin's disease: considerable progress and more to be achieved.
    Mathé G; Tubiana M
    Ser Haematol; 1973; 6(2):244-69. PubMed ID: 4361523
    [No Abstract]   [Full Text] [Related]  

  • 30. Lymphocyte subpopulations in Hodgkin's disease and non-Hodgkin's lymphoma and the effects of radiotherapy.
    Balasem AN; Barker CR
    Clin Radiol; 1984 Sep; 35(5):353-7. PubMed ID: 6236011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunodeficiencies in Hodgkin's Disease. Part II: B cell immunity, complement systems and phagocytic cell systems.
    Gupta S
    Clin Bull; 1981; 11(3):110-9. PubMed ID: 7039866
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunologic status of children with Hodgkin's disease (HD).
    Bogusławska-Jaworska J; Chybicka A; Pisarek J
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):725-31. PubMed ID: 6983869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hodgkin's disease. Results in diagnosis and treatment (author's transl)].
    Huhn D; Wilmanns W
    Klin Wochenschr; 1979 Apr; 57(8):371-81. PubMed ID: 156814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lymphocyte populations and serum immunoglobulins in patients with chronic lymphoid leukemia].
    Boretskiĭ VA
    Vrach Delo; 1982 Dec; (12):64-7. PubMed ID: 6984564
    [No Abstract]   [Full Text] [Related]  

  • 35. Changes of the cellular immunity tests during the evolution of Hodgkin's disease.
    Răileanu-Moţoiu I; Dumitrescu A; Costescu M; Mocanu N; Berceanu S
    Med Interne; 1983; 21(3):203-15. PubMed ID: 6665494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The immunological profile before and after splenectomy in homozygous beta-thalassemia].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1980 Jun; 88(2):161-9. PubMed ID: 6972519
    [No Abstract]   [Full Text] [Related]  

  • 37. The pathogenesis of Hodgkin's disease.
    Stuart AE
    J Pathol; 1978 Dec; 126(4):239-54. PubMed ID: 372510
    [No Abstract]   [Full Text] [Related]  

  • 38. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
    Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hodgkin's disease--an atypical immune reaction].
    Trepel F; Schick P
    Med Klin; 1977 Jun; 72(23):1003-18. PubMed ID: 327241
    [No Abstract]   [Full Text] [Related]  

  • 40. The response rate at chemotherapy in advanced Hodgkin's disease reflected by peripheral lymphocyte count.
    Krizan Z; Korec S; Bohunický L
    Neoplasma; 1978; 25(6):737-9. PubMed ID: 752119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.